Cargando…

1259. Activity of eravacycline against staphylococci isolated from periprosthetic joint infections

BACKGROUND: Perirosthetic joint infections (PJIs) are costly and difficult to treat. The most common causes of PJIs are Staphylococcus aureus and Staphylococcus epidermidis. Eravacycline is a newer tetracycline with promising activity against Gram-positive and negative bacteria which is approved for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuchenko, Georg, Schmidt-Malan, Suzannah, Patel, Robin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776843/ http://dx.doi.org/10.1093/ofid/ofaa439.1443

Ejemplares similares

691. Activity of TNP-2092 Against Biofilms Formed by Prosthetic Joint Infection-Associated Staphylococci
por: Fisher, Cody, et al.
Publicado: (2019)

1193. Human Transcriptomic Analysis of Periprosthetic Joint Infection
por: Masters, Thao, et al.
Publicado: (2020)

251. Poor Outcomes in the Treatment of Coagulase-Negative Staphylococci Periprosthetic Joint Infections
por: Case, Ayden, et al.
Publicado: (2021)

1255. In Vitro Activity of Vancapticin against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection
por: Cho, Hye-Kyung, et al.
Publicado: (2020)

1586. In Vitro Activity of Rifampin, Rifabutin, Rifapentine, and Rifaximin Against Biofilms Formed by Staphylococci Isolated from Prosthetic Joint Infection
por: Albano, Mariana, et al.
Publicado: (2019)

915. Global 2018 Surveillance of Eravacycline Against Gram-positive Pathogens, Including Resistant Isolates
por: Morgan, Steven, et al.
Publicado: (2020)

1577. Real-World, Multicenter Experience with Eravacycline for Various Infections
por: Alosaimy, Sara, et al.
Publicado: (2020)

1070. In vitro Activity of PLG0206 Against Isolates Commonly Found in Periprosthetic Joint Infections (PJI)
por: Huang, David, et al.
Publicado: (2021)

1613. Global 2018 Surveillance of Eravacycline Against Gram-negative Pathogens, Including Multi-drug Resistant Isolates
por: Lijfrock, Virgil, et al.
Publicado: (2020)

1243. Eravacycline in Bacteremia: A Case Series
por: Andrade, Justin A, et al.
Publicado: (2021)

1277. Antimicrobial Resistance in Periprosthetic Joint Infection over a Decade
por: Otero, Judith Alvarez, et al.
Publicado: (2023)

560. Repurposing Eravacycline for the Treatment of SARS-CoV-2 Infections
por: Reig, Núria, et al.
Publicado: (2020)

1270. Early Real-world Evidence in the Use of Eravacycline for the Management of Draconian Infections
por: Carr, Amy, et al.
Publicado: (2020)

712. Activity of Exebacase (CF-301) Against Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms on Orthopedic Kirschner Wires
por: Karau, Melissa J, et al.
Publicado: (2019)

1259. The Local Hospital Milieu and Healthcare-Associated VRE Acquisition
por: Zhou, Margaret, et al.
Publicado: (2018)

1295. Impact of Inoculum Size on Clinical Presentation in a Murine Knee Arthroplasty Model of Periprosthetic Joint Infection
por: Karau, Melissa J, et al.
Publicado: (2023)

P1259: CHARACTERIZATION OF VENETOCLAX RESISTANCE IN CELL MODELS OF MANTLE CELL LYMPHOMA
por: Granau, A., et al.
Publicado: (2022)

Activated mast cells in periprosthetic joint infection-associated tissue
por: Fisher, Cody R., et al.
Publicado: (2023)

324. Implant Sonication Improves Microbiologic Diagnosis of Elbow Prosthetic Joint Infection
por: Flurin, Laure, et al.
Publicado: (2020)

1586. A Comparative Analysis of In Vitro Susceptibilities of Vancomycin-Resistant Enterococci Against Doxycycline, Minocycline, Tigecycline, Eravacycline and Omadacycline
por: Chua, Mary Francine P, et al.
Publicado: (2020)

728. Activity of Eravacycline Against Contemporary Gram-Negative Clinical Isolates From New York City Hospitals
por: Iregui, Alejandro, et al.
Publicado: (2019)

1110. In Vivo Pharmacodynamics of Vancomycin Against Staphylococci in Young Infants
por: Gwee, Amanda, et al.
Publicado: (2021)

Profiling the Immune Response to Periprosthetic Joint Infection and Non-Infectious Arthroplasty Failure
por: Fisher, Cody R., et al.
Publicado: (2023)

In Vitro Activity of Eravacycline and Comparator Antimicrobials Against 143 Strains of Bacteroides Species.
por: Citron, Diane, et al.
Publicado: (2017)

Bulleidia extructa Periprosthetic Hip Joint Infection, United States
por: Kloesel, Benjamin, et al.
Publicado: (2013)

1259. Successful Inpatient Penicillin Delabeling in Minimal and Low Risk Penicillin Allergic Patients
por: Petrak, Robert, et al.
Publicado: (2023)

2132. Surveillance of Eravacycline Against Enterobacterales and Non-Fermenter Clinical Isolates, Including Resistant Isolates, Collected Worldwide from Multiple Infection Sites During 2021
por: Hawser, Stephen, et al.
Publicado: (2023)

Tu1259: CLINICAL FEATURES AND CHARACTERISTIC OF CHOLANGIOPATHY AFTER SEVERE COVID-19
por: Li, Tian, et al.
Publicado: (2022)

The evolutionary status of PSR 1259-63
por: Cominsky, L
Publicado: (1994)

390. Eravacycline combination therapy for severe, recurrent, or fulminant Clostridioides difficile infection
por: Morrison, Austin R, et al.
Publicado: (2022)

2133. Surveillance of Eravacycline Against Gram-positive Clinical Pathogens, Including Resistant Isolates, Collected Worldwide From Multiple Infection Sites During 2021
por: Hawser, Stephen, et al.
Publicado: (2023)

Transcriptomic analysis of Streptococcus agalactiae periprosthetic joint infection
por: Cho, Hye‐Kyung, et al.
Publicado: (2021)

1259. Household Income and Its Relationship with Patient-Reported Outcomes Among Older People Living with HIV
por: Mazonson, Peter, et al.
Publicado: (2019)

Clinical Characteristics and Outcomes of Prosthetic Joint Infection Caused by Small Colony Variant Staphylococci
por: Tande, Aaron J., et al.
Publicado: (2014)

688. In Vitro Activity of Eravacycline, a New Tetracycline Analog, and Comparators Against the Six Most Commonly Isolated Ribotypes of Clostridioides difficile
por: Basseres, Eugenie, et al.
Publicado: (2019)

1040. Knee Explant Analysis (KnEA) Using PLG0206 in Periprosthetic Joint Infection (KnEA Study)
por: Huang, David, et al.
Publicado: (2021)

243. Analysis of Risk Factors Associated with Adverse Outcomes Following Calcium Sulfate Bead Use in Periprosthetic Joint Infections
por: Pham, Christine, et al.
Publicado: (2021)

1430. Eravacycline associated hypofibrinogenemia during treatment of M.abscessus
por: Rausch, Ethan, et al.
Publicado: (2022)

In Vitro Activity of Rifampin, Rifabutin, and Rifapentine against Enterococci and Streptococci from Periprosthetic Joint Infection
por: Albano, Mariana, et al.
Publicado: (2021)

P1259: HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS AMELIORATE ACUTE GRAFT VERSUS HOST DISEASE BY ELEVATING PHYTOSPHINGOSINE
por: Yang, Guancui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_aoc0lqm58emo69tmgmgeeh0llt